0001127602-21-023425.txt : 20210810 0001127602-21-023425.hdr.sgml : 20210810 20210810114255 ACCESSION NUMBER: 0001127602-21-023425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210806 FILED AS OF DATE: 20210810 DATE AS OF CHANGE: 20210810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOSTER JAMES C CENTRAL INDEX KEY: 0001141722 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 211159023 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1226 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-08-06 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001141722 FOSTER JAMES C 251 BALLARDVALE STREET WILMINGTON MA 01887 1 1 Chairman, President and CEO Common Stock 2021-08-06 5 G 0 E 2500 0 D 212299 D Common Stock 2021-08-06 4 S 0 3822 400.8889 D 208477 D Common Stock 2021-08-06 4 S 0 3718 401.7747 D 204759 D Common Stock 2021-08-06 4 S 0 1552 402.7109 D 203207 D Common Stock 2021-08-06 4 S 0 808 403.9163 D 202399 D Common Stock 2021-08-06 4 S 0 100 405.00 D 202299 D Common Stock 19013 I 2019 GRAT Common Stock 17579 I 2020 GRAT Common Stock 340 I By Trust Common Stock 750 I By Trust Common Stock 2250 I By Trust Common Stock 10000 I Held By Spouse his transaction was executed in multiple trades at prices ranging from $400.31 to $401.305. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $401.31 to $402.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $402.33 to $403.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $403.385 to $404.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected /s/ James C. Foster 2021-08-10